‘Miracle’ Alzheimer’s drug WON’T be offered on the NHS after drug watchdog rules benefits are too small to justify the eye-watering ‘£1bn-a-year’ roll-out cost, but it will be available to private patients who can pay £20,000 a year
Brits at risk of Alzheimer’s will miss out on a ‘miracle’ drug to treat the incurable disease on the NHS, health chiefs today announced. Lecanemab has been proven to slow the progress of the memory-robbing illness in its early stages. It was today approved by medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). But draft